Subgroup Modelling and Use of External Evidence in Precision Oncology Appraisals: An External Assessment Group Perspective on the NICE Single Technology Appraisal of Zolbetuximab for Untreated CLDN18.2-Positive HER2-Negative Unresectable Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma.

Saved in:
Bibliographic Details
Title: Subgroup Modelling and Use of External Evidence in Precision Oncology Appraisals: An External Assessment Group Perspective on the NICE Single Technology Appraisal of Zolbetuximab for Untreated CLDN18.2-Positive HER2-Negative Unresectable Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma.
Authors: Scholte M; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands. Mirre.Scholte@radboudumc.nl.; Departments of Radiology and IQ Health, Radboud University Medical Centre, Nijmegen, The Netherlands. Mirre.Scholte@radboudumc.nl., Fernández Coves A; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands., Yang H; Kleijnen Systematic Reviews Limited, York, UK., Armstrong N; Kleijnen Systematic Reviews Limited, York, UK., McDermott K; Kleijnen Systematic Reviews Limited, York, UK., Tian X; Kleijnen Systematic Reviews Limited, York, UK., Stirk L; Kleijnen Systematic Reviews Limited, York, UK., Wolff R; Kleijnen Systematic Reviews Limited, York, UK., Joore MA; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands., Grimm SE; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands.
Source: PharmacoEconomics [Pharmacoeconomics] 2026 May; Vol. 44 (5), pp. 509-513. Date of Electronic Publication: 2026 Jan 25.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1179-2027
DOI:10.1007/s40273-026-01591-7